Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 32.70% vs -37.99% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 18.18% vs 0.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.20% vs -1.32% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 16.36% vs 5.95% in Mar 2024
Compare Balance Sheet Results of Shukra Pharma.
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
43.79
10.54
33.25
315.46%
Share Warrants & Outstandings
Total Reserve
19.05
1,041.80
-1,022.75
-98.17%
Shareholder's Funds
62.84
1,058.63
-995.79
-94.06%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
3.11
19.67
-16.56
-84.19%
Secured Loans
1.64
19.67
-18.03
-91.66%
Unsecured Loans
1.48
0.00
1.48
0.00%
Deferred Tax Assets / Liabilities
3.41
-9.09
12.50
137.51%
Other Long Term Liabilities
0.13
12.47
-12.34
-98.96%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
4.36
-4.36
-100.00%
Total Non-Current Liabilities
6.65
27.42
-20.77
-75.75%
Current Liabilities
Trade Payables
9.22
60.32
-51.10
-84.71%
Other Current Liabilities
4.27
32.41
-28.14
-86.83%
Short Term Borrowings
1.06
31.34
-30.28
-96.62%
Short Term Provisions
2.74
0.49
2.25
459.18%
Total Current Liabilities
17.28
124.55
-107.27
-86.13%
Total Liabilities
86.77
1,210.60
-1,123.83
-92.83%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
43.42
477.72
-434.30
-90.91%
Less: Accumulated Depreciation
24.03
109.84
-85.81
-78.12%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
19.40
367.89
-348.49
-94.73%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.95
20.58
-18.63
-90.52%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
19.37
-19.37
-100.00%
Long Term Loans & Advances
0.00
16.24
-16.24
-100.00%
Other Non Current Assets
0.00
18.84
-18.84
-100.00%
Total Non-Current Assets
21.34
442.91
-421.57
-95.18%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
9.95
81.94
-71.99
-87.86%
Sundry Debtors
8.77
428.25
-419.48
-97.95%
Cash and Bank
12.12
171.11
-158.99
-92.92%
Other Current Assets
20.17
23.69
-3.52
-14.86%
Short Term Loans and Advances
14.42
62.70
-48.28
-77.00%
Total Current Assets
65.43
767.69
-702.26
-91.48%
Net Current Assets (Including Current Investments)
48.14
643.14
-595.00
-92.51%
Total Current Assets Excluding Current Investments
65.43
767.69
-702.26
-91.48%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
86.77
1,210.60
-1,123.83
-92.83%
Contingent Liabilities
1.40
7.08
-5.68
-80.23%
Total Debt
4.18
51.01
-46.83
-91.81%
Book Value per share (adjusted)
1.44
100.47
-99.03
-98.57%
Annual - Borrowings
Borrowings 4.18 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 32.70% vs -37.99% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.13 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 18.18% vs 0.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 21.34 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.20% vs -1.32% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 65.43 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 16.36% vs 5.95% in Mar 2024






